Hjem › Prostatakræft › North Carolina
Prostatakræft kliniske forsøg i North Carolina
47 studier for Prostatakræft søger deltagere på steder i North Carolina.
Byer i North Carolina
- Durham32 studier
- Charlotte7 studier
- Winston-Salem5 studier
- Concord5 studier
- Asheville3 studier
- New Bern3 studier
Officiel studietekst (engelsk)
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Duke University, Durham
RekruttererFase 1/2
Alder 12 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT04585750Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
- Durham VA Medical Center, Durham
- Duke University Medical Center, Durham
- FirstHealth of the Carolinas-Moore Regional Hospital, Pinehurst
RekruttererFase 3
Alder 18 og opefter · Mænd · Opdateret 2. okt. 2026 · NCT06931340Distance-Based Exercise to Preserve Function and Prevent Disability
- Novant Health Cancer Institute - Kernersville, Kernersville
- Novant Health Cancer Institute - Mount Airy, Mount Airy
- Novant Health Forsyth Medical Center, Winston-Salem
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT07059884Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- AdventHealth Infusion Center Asheville, Asheville
- Southeastern Medical Oncology Center-Clinton, Clinton
- AdventHealth Infusion Center Haywood, Clyde
- og 6 flere
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 40 til 75 · Alle køn · Opdateret 2. okt. 2026 · NCT05334069Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT06632977Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill
- Margaret R Pardee Memorial Hospital, Hendersonville
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT03866382A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
- Atrium Health Levine Cancer Institute, Charlotte
RekruttererFase 1
Alder 18 og opefter · Mænd · Opdateret 28. sep. 2026 · NCT06095089DESTINY-PANTUMOUR04
- Research Site, Durham
- Research Site, Wilson
RekruttererObservationsstudie
Alder 18 til 130 · Alle køn · Opdateret 25. sep. 2026 · NCT07124000Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
- Duke University Medical Center, Durham
RekruttererFase 1/2
Alder 18 og opefter · Mænd · Opdateret 25. sep. 2026 · NCT06800313This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
- Duke Cancer Center Cary, Cary
- Duke University Medical Center (location of scans), Durham
- Duke University Medical Center - Duke Cancer Center, Durham
- og 5 flere
RekruttererFase 3
Alder 18 og opefter · Mænd · Opdateret 24. sep. 2026 · NCT07028853High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
- Durham VA Medical Center, Durham, NC, Durham
- Salisbury W.G. (Bill) Hefner VA Medical Center, Salisbury, NC, Salisbury
RekruttererFase 2
Alder 18 og opefter · Mænd · Opdateret 17. sep. 2026 · NCT05011383Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
- Durham VA Medical Center, Durham, NC, Durham
RekruttererFase 2
Alder 18 og opefter · Mænd · Opdateret 17. sep. 2026 · NCT04038502Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer
- Duke University Medical Center, Durham
RekruttererFase 1
Alder 18 og opefter · Mænd · Opdateret 15. sep. 2026 · NCT07493512Sacral Neuromodulation for Male Overactive Bladder (MOAB)
- Associated Urologists of North Carolina (AUNC), Raleigh
Rekrutterer
Alder 18 og opefter · Mænd · Opdateret 14. sep. 2026 · NCT06511141Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
- Duke University Medical Center, Durham
RekruttererFase 3
Alder 18 og opefter · Mænd · Opdateret 11. sep. 2026 · NCT06056830Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
- Durham VA Medical Center, Durham
- CarolinaEast Medical Center, New Bern
RekruttererFase 3
Alder 18 og opefter · Mænd · Opdateret 10. sep. 2026 · NCT05946213A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)
- Urology Specialists of the Carolinas - University Place, Charlotte
RekruttererFase 3
Alder 18 og opefter · Mænd · Opdateret 3. sep. 2026 · NCT07723248The Vanguard Study: Testing a New Way to Screen for Cancer
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill
- Durham VA Medical Center, Durham
RekruttererFrivillige med god helbredstilstand velkomne
Alder 45 til 75 · Alle køn · Opdateret 2. sep. 2026 · NCT06995898COMPASS Study for Metastatic Castration-resistant Prostate Cancer
- Duke University, Durham
RekruttererObservationsstudie
Alder 18 og opefter · Mænd · Opdateret 27. aug. 2026 · NCT07050433Study of Oral MRT-2359 With Apalutamide in Prostate Cancer
- Levine Cancer Institute, Charlotte
RekruttererFase 2
Alder 18 og opefter · Mænd · Opdateret 24. aug. 2026 · NCT07745361Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
- Duke University Medical Center, Durham
RekruttererFase 1
Alder 18 og opefter · Mænd · Opdateret 21. aug. 2026 · NCT04221542A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
- Duke University medical center, Durham
RekruttererFase 1/2
Alder 18 og opefter · Mænd · Opdateret 20. aug. 2026 · NCT06785636Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
- ECU Health Oncology Kinston, Kinston
RekruttererFase 3
Alder 18 og opefter · Mænd · Opdateret 19. aug. 2026 · NCT04423211A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
- Duke University Medical Center - Duke Cancer Center, Durham
RekruttererFase 2
Alder 18 og opefter · Mænd · Opdateret 17. aug. 2026 · NCT06842498FOG-001 in Locally Advanced or Metastatic Solid Tumors
- Duke University, Durham
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 17. aug. 2026 · NCT05919264A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
- Duke Cancer Institute, Durham
RekruttererFase 1
Alder 18 og opefter · Mænd · Opdateret 10. aug. 2026 · NCT06067841A Study of DM002 in Patients With Advanced Solid Tumors
- Carolina BioOncology Institute, LLC, Huntersville
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 7. aug. 2026 · NCT06751329Validation of a Platelet Proteomic Assay for Diagnosing and Monitoring Prostate Cancer
- Duke University, Durham
RekruttererObservationsstudie
Alder 40 og opefter · Mænd · Opdateret 6. aug. 2026 · NCT07144228Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
- Carolinas Medical Center/Levine Cancer Institute, Charlotte
- Atrium Health University City/LCI-University, Charlotte
- Levine Cancer Institute-Ballantyne, Charlotte
- og 9 flere
RekruttererFase 3
Alder 18 og opefter · Mænd · Opdateret 14. jul. 2026 · NCT06592924Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells
- Wake Forest University Health Sciences, Winston-Salem
RekruttererFase 2
Alder 18 og opefter · Mænd · Opdateret 14. jul. 2026 · NCT05691465A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
- Duke Cancer Center, Durham
RekruttererFase 1
Alder 18 og opefter · Mænd · Opdateret 9. jul. 2026 · NCT07103018Study of ORIC-944 in Patients With Metastatic Prostate Cancer
- Levine Cancer Institute, Charlotte
RekruttererFase 1
Alder 18 og opefter · Mænd · Opdateret 9. jul. 2026 · NCT05413421Integrated Cancer Repository for Cancer Research
- Cape Fear Valley Health System, Fayetteville
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 19 til 110 · Alle køn · Opdateret 29. jun. 2026 · NCT02012699A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer
- Duke University, Durham
RekruttererFase 1/2
Alder 18 og opefter · Mænd · Opdateret 25. jun. 2026 · NCT06457919Artificial Intelligence (AI)-Enhanced Pretreatment Peer-review Process to Improve Patient Safety in Radiation Oncology
- University of North Carolina at Chapel Hill, Department of Radiation Oncology, Chapel Hill
RekruttererFrivillige med god helbredstilstand velkomne
Alder 18 og opefter · Alle køn · Opdateret 23. jun. 2026 · NCT07463833Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
- W.G. Bill Hefner Medical Center, Salisbury
RekruttererFase 2
Alder 18 og opefter · Mænd · Opdateret 15. jun. 2026 · NCT05422911Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
- Duke University Medical Center, Durham
RekruttererFase 4
Alder 18 til 100 · Mænd · Opdateret 4. jun. 2026 · NCT05803941International Registry for Men With Advanced Prostate Cancer (IRONMAN)
- University of North Carolina at Chapel Hill, Chapel Hill
- Durham VA Medical Center, Durham
- Duke Cancer Network, Durham
- og 1 flere
RekruttererObservationsstudie
Alder 21 og opefter · Mænd · Opdateret 22. maj 2026 · NCT03151629Fatty Acid Synthase Inhibition in Castration Refractory Prostate Cancer
- W.G. Bill Hefner VA Medical Center, Salisbury
- Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem
RekruttererFase 2
Alder 18 og opefter · Mænd · Opdateret 13. apr. 2026 · NCT04337580Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
- Durham VA Medical Center, Durham, NC, Durham
RekruttererFase 2/3
Alder 18 og opefter · Mænd · Opdateret 8. apr. 2026 · NCT04787744Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.